Glycochenodeoxycholic acid-d7 (sodium)

CAT:
804-HY-N2334AS-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Glycochenodeoxycholic acid-d7 (sodium) - image 1

Glycochenodeoxycholic acid-d7 (sodium)

  • UNSPSC Description:

    Glycochenodeoxycholic acid-d7 (sodium) is the deuterium labeled Glycochenodeoxycholic acid (sodium salt). Glycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) induces hepatocyte apoptosis[1][2].
  • Target Antigen:

    Apoptosis; Endogenous Metabolite; Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Apoptosis;Metabolic Enzyme/Protease;Others
  • Field of Research:

    Cancer
  • Solubility:

    10 mM in DMSO
  • Smiles:

    C[C@@]12[C@](CC[C@]2([H])[C@H](C)C([2H])([2H])CC(NCC(O[Na])=O)=O)([H])[C@@]3([H])[C@]([C@@]4([C@](C([2H])([2H])[C@@](O)([2H])C([2H])([2H])C4)([H])C[C@H]3O)C)([H])CC1
  • Molecular Weight:

    478.65
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |[2]Liang S, et al. Effect of quercetin 7-rhamnoside on glycochenodeoxycholic acid-induced L-02 human normal livercell apoptosis. Int J Mol Med. 2013 Aug;32(2):323-30.|[3]Gonzalez B, et al. Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular PKC activity. Mol Cell Biochem. 2000 Apr;207(1-2):19-27.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported